Antibiotics and risk of subsequent first-time acute myocardial infarction

JAMA

Volumn 281, Issue 5, 1999, Pages 427-431

  Meier, Christoph R ^a   Derby, Laura E ^a   Jick, Susan S ^a   Vasilakis, Catherine ^a   Jick, Hershel ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; MACROLIDE; MINOCYCLINE; NORFLOXACIN; OFLOXACIN; OXYTETRACYCLINE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM;

ACUTE HEART INFARCTION; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY RISK; CORRELATION FUNCTION; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0033518530     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.281.5.427     Document Type: Article

References (22)

1. Saikku P, Leinonen M, Mattila K, et al. Serologic evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988;2:983-986.
2. Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study Ann Intern Med. 1992;116:273-278.
3. Thorn DH, Grayston JT, Siscovick DS, Wang S-P, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary heart disease. JAMA. 1992;268:68-72.
4. Grayston JT. Chlamydia in atherosclerosis. Circulation. 1993;87:1408-1409.
5. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 1997; 350:430-436.
6. Gupta S, Camm AJ. Chlamydia pneumoniae and coronary heart disease: coincidence, association, or causation? BMJ. 1997;314:1778-1779.
7. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation. 1997;96:404-407.
8. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet. 1997;350:404-407.
9. Mattila KJ, Nieminen MS, Valtonen VV, et al. Association between dental health and acute myocardial infarction. BMJ. 1989;298:779-781.
10. Wimmer MLJ, Sandmann-Strupp R, Saikku P, Haberl RL. Association of chlamydial infection with cerebrovascular disease. Stroke. 1996;27:2207-2210.
11. Grayston JT, Kuo C, Wang S, Altman J. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med. 1986;315:161-168.
12. Falck G, Heyman L, Gnarpe J, Gnarpe H. Chlamydia pneumoniae (TWAR): a common agent in acute bronchitis. Scand J Infect Dis. 1994;26:179-187.
13. Kauppinen M, Saikku P. Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment. Clin Infect Dis. 1995;21 (suppl):S244-S252.
14. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ. 1991;302:766-768.
15. Jick H, Terris BZ, Derby LE, Jick SS. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiol Drug Safety. 1992;1:347-349.
16. Walley T, Mantgani A. The UK General Practice Research Database. Lancet. 1997;350:1097-1099.
17. Jick H. A database worth saving. Lancet. 1997; 350:1045.
18. Jick H, Derby LE, Gurewich V, Vasilakis C. The risk of myocardial infarction associated with antihypertensive drug treatment in persons with uncomplicated essential hypertension. Pharmacotherapy. 1996;16:321-326.
19. Jick H, Vasilakis C, Derby LE. Antihypertensive drugs and fatal myocardial infarction in persons with uncomplicated hypertension. Epidemiology. 1997;8:446-448.
20. Meier CR, Jick SS, Derby LE, Vasilakis C, Jick H. Acute respiratory tract infections and risk of first-time acute myocardial infarction. Lancet. 1998;351:1467-1471.
21. Hammerschlag MR. Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae. Antimicrob Agents Chemother. 1994;38:1873-1878.
22. Hammerschlag MR, Qumei KK, Roblin PM. In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae. Antimicrob Agents Chemother. 1992; 36:1573-1574.